YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Merck to acquire cancer-treatment biotech firm

Posted online

Merck & Co. Inc. announced plans to purchase biopharmaceutical company Tilos Therapeutics.

The deal for the cancer-treatment biotechnology firm could be valued at up to $773 million.

The deal includes an up-front payment and milestone payouts.

Read more from MarketWatch.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences